Trusted by the world’s leading institutions

clients clients clients clients clients clients clients clients clients clients clients
Newswise: Study Shows Polygenic Risk Score (PGS) Could Predict Breast Cancer Survival Outcomes
Release date: 30-May-2024 4:00 PM EDT
Study Shows Polygenic Risk Score (PGS) Could Predict Breast Cancer Survival Outcomes
Roswell Park Comprehensive Cancer Center

Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer. Arya Mariam Roy, MBBS, Hematology/Oncology Fellow (Class of 2024) at Roswell Park Comprehensive Cancer Center, will share the results of that study as the first and presenting author of “Breast cancer polygenic risk score and patient survival outcomes in the Pathways study” at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31-June 4.

Newswise: 
Rising Syphilis Cases Prompt More Testing During Pregnancy
Release date: 30-May-2024 3:05 PM EDT
Rising Syphilis Cases Prompt More Testing During Pregnancy
Vanderbilt University Medical Center

Syphilis numbers are on the rise in Tennessee: In women, the number of cases has risen 311%, from 290 cases in 2017 to 1,191 in 2022.

Newswise: How community stress affects Black Americans’ mental health and wellbeing
Release date: 30-May-2024 3:05 PM EDT
How community stress affects Black Americans’ mental health and wellbeing
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Residential segregation is an example of the long history of structural racism in the United States. Black Americans are more likely to live in low-quality neighborhoods, which contributes to disparities in health outcomes. A new study from the University of Illinois Urbana-Champaign looks at how community stress affects the mental and emotional health of Black men and women in the U.S.

Release date: 30-May-2024 3:05 PM EDT
Promising New Treatment for Patients with HR+ HER-2 Negative Metastatic Breast Cancer
Yale Cancer Center/Smilow Cancer Hospital

New research from Yale Cancer Center reveals first-of-its-kind data from a phase I study in patients with hormone receptor positive HER2-negative metastatic breast cancer. The results, which assess the safety and efficacy of a treatment known as PF-07248144, offer new hope for treating this aggressive type of breast cancer.

Newswise: Study: Access to Targeted Lung Cancer Drug Is Cost-Prohibitive Globally
Release date: 30-May-2024 2:05 PM EDT
Study: Access to Targeted Lung Cancer Drug Is Cost-Prohibitive Globally
Sylvester Comprehensive Cancer Center

A new study that examined the cost-effectiveness of durvalumab, a targeted immunotherapy for lung cancer, could help guide drug-pricing strategies to reduce financial burdens and increase the number of patients who benefit from treatment.

Release date: 30-May-2024 2:05 PM EDT
Cognitive Science Researcher Establishes UC San Diego’s First Fellowship in the Field
University of California San Diego

Susan Chipman, a pioneer in the field of cognitive science, has pledged a $1 million planned gift to the University of California San Diego's Department of Cognitive Science. The Susan E.F. Chipman and Robert G. Fitzgerald Graduate Fellowship Fund in Cognitive Science is the first of its kind in the UC San Diego department, which was the world's first department established in cognitive science.

Release date: 30-May-2024 2:00 PM EDT
Migraine surgery reduces headache days, reports Plastic and Reconstructive Surgery®
Wolters Kluwer Health: Lippincott

For patients with chronic migraine, nerve decompression surgery effectively reduces the number of headache days – the outcome measure preferred by neurologists – along with other measures including the frequency and intensity of migraine attacks, reports a study in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: UW–Madison scientists develop most sensitive way to observe single molecules
Release date: 30-May-2024 1:05 PM EDT
UW–Madison scientists develop most sensitive way to observe single molecules
University of Wisconsin–Madison

Scientists at the University of Wisconsin–Madison have developed the most sensitive method yet for detecting and profiling a single molecule — unlocking a new tool that holds potential for better understanding how the building blocks of matter interact with each other. The new method could have implications for pursuits as varied as drug discovery and the development of advanced materials.

Newswise: A nanomaterial one-two punch quickly heals wounds in diabetic animal model
Release date: 30-May-2024 1:05 PM EDT
A nanomaterial one-two punch quickly heals wounds in diabetic animal model
National Institute of Biomedical Imaging and Bioengineering

Wounds that are superficial for some can be life-threatening for others. With diabetic wounds, healing can be slow, particularly in the feet, increasing the tissue’s susceptibility to infection. Foot ulcers and other diabetic foot complications have similar mortality rates to some cancers, yet progress toward improved treatments has plateaued.

Newswise: Utah FORGE achieves crucial geothermal milestone
Release date: 30-May-2024 1:05 PM EDT
Utah FORGE achieves crucial geothermal milestone
University of Utah

A major University of Utah-led geothermal research project, funded by the U.S. Department of Energy (DOE), achieved a critical breakthrough in April after hydraulically stimulating and circulating water through heated rock formations a mile and a half beneath its drill site in the Utah desert and bringing hot water to the surface.


close
1.6825